We conducted an open prospective study on the value of testing pudendal nerve conduction (PNC) in 45 diabetic and 32 nondiabetic men with documented erectile dysfunction (ED) of at least six months duration. All subjects underwent PNC by the same investigator using the MedcelecaTECA Sapphire device with calibration parameters of sweep 10 msadiv an amplitude of 200 mVadiv. No statistically signi®cant differences was found in the mean bulbocavernosus re¯ex (BCR) latencies between the nondiabetics (33.6 msadiv AE 4.1) and the diabetics (37.5 msadiv AE 9.1) (P b 0.05). Our results show that electrophysiological measurement of the BCR in diabetics is not a useful diagnostic test and emphasize the importance of a multifactorial evaluation of diabetic ED.
Introduction
Diabetes mellitus (DM) is a major cause of organic erectile dysfunction (ED) which is characteristically progressive and can appear at any age. It has been reported that more than half of all male diabetics have ED due to multiple etiologies, with peripheral neuropathy being the principal cause. 1 In recent years, much effort has been expended to devise a clinical test for the diagnosis of neurological damage in ED. Several tests were proposed for the evaluation of autonomic (parasympathetic and sympathetic) and somatic penile innervation (pudendal nerve), including dorsal nerve evoked potential studies (DN-SEP), sacral evoked response studies (SER), corpus cavernosum EMG (CC-EMG), biothesiometry, and single potential analysis of cavernous electrical activity. None of these attempts has yielded a comprehensive test for detecting neurological de®-cits. Some authors contend that pudendal nerve conduction (PNC) is an objective test for diagnosing neurogenic ED. 2, 3 Others showed that pathological PNC latency appears relatively late in diabetic neuropathy and is thus not a reliable test in the diagnosis of neurogenic ED. 4, 5 The controversial results published in the literature about the value of PNC in diagnosing neurogenic ED motivated us to conduct a prospective study in which we compared the electrophysiological results of bulbocavernosus re¯ex (BCR) in patients with and without DM and the relationship of BCR latency to the patient's age and duration of his DM.
Materials and methods
Seventy-seven men aged 34 to 71 y (mean age 54.6 AE 11.3 y) were enrolled in this open prospective study. They were referred for con®rmation of clinically suspected neurogenic ED. Before PNC test was conducted, all subjects underwent general physical and neurological examinations, routine laboratory tests including endocrine pro®le, and monitoring of nocturnal penile tumescence by the NPTaRigiScan device (Dacomed Ltd, MI, USA) during one or two nights. Penile blood circulation was measured by the color Doppler ± duplex technique using a small parts linear transducer of 7.5 MHz B&K Medical System 3535 (Denmark) ultrasound machine.
was evaluated for long-term blood glucose control some of them. Twenty-eight of these patients had minor signs of peripheral neuropathy (slight distal sensory loss in lower limbs, absent Achilles tendon jerks, etc). The control group included 32 nondiabetic men with ED (mean age 54.8 AE 10.3 y). all complained of ED and had no lesions of the sacral nervous system nor peripheral or central nervous system de®cit. We had performed this test in several healthy volunteers, but it was very dif®cult to recruit a statistically suf®cient number of healthy men for this invasive and uncomfortable test. Thus, we used nondiabetic patients with ED as controls. However, patients with abnormal peroneal or sural nerve conduction parameters were excluded in order to avoid possible somatic neuropathy as a cause of abnormality in the test results. In 19 out of the 32 non-diabetic patients (controls), the diagnosis of ED was associated with arterial insuf®ciency, ®ve patients had veno-occlusive ED, and the ED was associated with medications administration because of various cardiovascular disorders in eight. The NPTaRigiScan test that had been conducted during one or two nights in all of the controls showed pathological ®ndings. In patients with arterial insuf®ciency, the peak systolic velocity (PSV) was less than 25 mlas, while the end diastolic velocity (EDV) was more than 5 mlas before and 20 min after the intracavernous injection of vasoactive drug (PGE1 10 mg) in patients with clinical signs of veno-occlusive ED.
The mean duration of the diabetes mellitus was 12.6 AE 5.3 y. Of the 45 diabetics, 11 were treated with injections of insulin and 34 were on oral antidiabetic medications. The NPTaRigiScan revealed pathological ®ndings and the dynamic color duplex Doppler (DCDD) demonstrated arterial or mixed circulatory de®cit in all these 45 patients.
Methods
PNC was performed by the MedelecaTECA Sapphire EMG apparatus with calibration parameters of sweep 10 msadiv and amplitude of 200 mVadiv. A concentric needle electrode was used to record signals from the bulbocavernosus muscles. Testing of evoked responses of the penile dorsal nerve was carried out by a bipolar stimulator. Stimulation of the pudendal nerve was used to effect re¯ective contraction of the bulbocavernosus muscle. The two recorded components of this re¯ex were an early response and a late one (normal 35 ± 42 ms). The latency was measured at the beginning of the stimulus to the onset of the ®rst negative peak. The ampli®er band pass was 3 Hz ± 5 kHz.
Statistical analysis
T-test independent samples were used to compare diabetic and nondiabetic patients with respect to amplitude and latency. A one-way analysis of variants (ANOVA) was performed to compare BCR latencies in the various age groups.
Results
The measured mean amplitude for the controls was 260.6 mVadiv (s.d. AE 76.3) and 232.7 mVadiv (s.d. AE 106.4) for the diabetics. Although there was a difference in the measured amplitude of PNC in some diabetic and nondiabetic patients (Figure 1) , the difference did not reach statistical signi®cance (P`0.05).
The mean of the BCR latencies in the nondiabetic ED group was 33.6 msadiv (s.d. AE 4.1) and 37.5 msadiv (s.d. AE 9.1) in the diabetic ED group. Similarly to the comparison of amplitude measurement, there was no statistically signi®cant difference in BCR latency between the two groups (P`0.05).
The BCR latency was slightly longer in the older patients compared to the younger ones in both groups (P NS), with a tendency to be signi®cantly longer in patients who were treated with insulin injections.
Discussion
The electrophysiologically induced BCR measures the somatic re¯ex pathway from the dorsal nerve of the penis, via the sensory pudendal afferent limb, the spinal sacral segment S2 ± S4, and the motor pudendal efferent limb. There will be no response when the BCR arcs are interrupted, and the BCR will be prolonged when afferent and efferent limbs are not completely destroyed. 1, 2 Figure 1 Bulbocavernosus re¯ex in normal (A) and diabetic (B) subjects.
Pudendal nerve conduction in erectile dysfunction in diabetics B Fishel et al
In diabetic peripheral neuropathy, loss of myelinated nerve ®bers is the most prominent ®nding. Since nerve conduction studies evaluate only the largest, fastest conducting myelinated ®bers, a substantial percentage of small ®ber neuropathies will not be detected. Nerve conduction studies can be normal as long as some fast-conducting ®bers remain intact. 3 ± 6 Vardi et al's study electrophysiologically demonstrated peripheral neuropathy in 42% of diabetic patients with ED compared with 15% diabetics without ED. 7 They suggested that electrophysiological investigation of the lower extremities should be part of the PNC study. Con®rmation of this contention was provided by Mehta et al who reported that BCR is not adequate in the workup of impotence, since evidence of abnormal conduction was found more in the peroneal and sural nerves than in the BCR. 8 Ertekin et al wrote that the impotence seen in DM is mainly due to involvement of autonomic nerve ®bers. 9 However, according to Espino, it would be rare for a patient to have an isolated autonomic neuropathy which in no way affects the somatic nerves. 10 To date, we have no sensitive and speci®c diagnostic tests which have also been used in the evaluation of the autonomic nervous system and the sensitivity of PNC is only about 20%. 2, 3, 8, 11 It is not surprising that the reported BCR results were so varied. To a large extent, these differences may be explained by patient selection: more of Gallai and Mazzotta's patients had a longer history of insulindependent diabetes and they found a prolonged mean latency of BCR in their patients taken as a whole. 12 In contrast, early neuropathy in diabetic patients who are not insulin dependent shows fewer changes in the wave form with almost normal latency. In our study, we were not able to demonstrate such a correlation. Although we found BCR latency to be slightly longer in older than in younger patients in both groups, this may be the result of a general decrease in BCR latency in a generally aged population. Our ®nding that the age of patients has no signi®cant difference in BCR latency between the compared groups is also in good correlation with the ®ndings of several other investigators. 4, 10, 12 It is possible that the age-related differences in pudendal motor nerve latency are not representative of a neurogenic syndrome of the nerve but are linked to a defect in neuro-muscular transmission and aging of the muscle and nerve ®bers.
Our negative ®ndings demonstrate that the routine pudendal nerve conduction test in the assessment of ED is noncontributory because of the lack of a signi®cant correlation between BCR latency and ED in our groups. This suggests that an autonomic dysfunction, vascular insuf®ciency andaor psychogenic factors are the likely dominant causes of ED.
Our study supports the results of Herbaut et al who contend that BCR is not reliable in diagnosing diabetic impotence and that further speci®c tests are needed to investigate pelvic autonomic neuropathy. 13 Finally, although we were able to demonstrate that BCR latency had a tendency to be signi®cantly longer in patients treated with insulin injections, the small number of patients in both diabetic subgroups and the lack of adequate information regarding the in¯uence of the patient status being insulin-dependent versus non-insulin-dependent precluded our arriving at any de®nite conclusions. Knowing the affect of this parameter would greatly assist clinicians in understanding the complexity of the ED accompanying DM. The multifactorial nature of ED in diabetic patients can decrease the possible success of therapy or be an indication that the therapeutic strategies should be more aggressive.
